Organ-specific immune checkpoint inhibitor treatment in lung cancer: a systematic review and meta-analysis

OBJECTIVES: Based on the acknowledged organ-specific immune microenvironment, little is known regarding the efficacy of immunotherapy in patients with lung cancer according to metastatic sites. This meta-analysis aimed to explore the efficacy of immune checkpoint inhibitors (ICIs) vs chemotherapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shufei, Zhang, Shuyang, Xu, Haiyan, Yang, Guangjian, Xu, Fei, Yang, Liang, Chen, Duo, An, Guangyu, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030562/
https://www.ncbi.nlm.nih.gov/pubmed/36931679
http://dx.doi.org/10.1136/bmjopen-2021-059457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030562/
https://www.ncbi.nlm.nih.gov/pubmed/36931679
http://dx.doi.org/10.1136/bmjopen-2021-059457

Ejemplares similares